Verismo Therapeutics, .
About
Verismo Therapeutics is pioneering KIR-CAR T cell therapy, a next-generation approach designed to overcome the limitations of traditional CAR T therapies for solid tumors. Their unique SynKIR™ platform, inspired by natural killer cell receptors, aims to reduce T cell exhaustion and maintain long-term efficacy in challenging tumor microenvironments. The company is developing this technology for the treatment of solid tumors.
Technology stack
detected 2026-06-28CDN
Cloudflare
Email
Microsoft 365
Stack
jQuery
Bootstrap
WordPress
Analytics
Google Tag Manager
SEO
Yoast SEO
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Verismo Therapeutics, . do?
Verismo Therapeutics is pioneering KIR-CAR T cell therapy, a next-generation approach designed to overcome the limitations of traditional CAR T therapies for solid tumors. Their unique SynKIR™ platform, inspired by natural killer cell receptors, aims to reduce T cell exhaustion and maintain long-term efficacy in challenging tumor microenvironments. The company is developing this technology for the treatment of solid tumors.
Where is Verismo Therapeutics, . headquartered?
Verismo Therapeutics, . is headquartered in Philadelphia, United States.
When was Verismo Therapeutics, . founded?
Verismo Therapeutics, . was founded in 2017.
What industry does Verismo Therapeutics, . operate in?
Verismo Therapeutics, . operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, CAR T-cell Therapy.